
EDBI
Description
EDBI, or EDB Investments, stands as the dedicated corporate investment arm of the Singapore Economic Development Board (EDB), a statutory board under Singapore's Ministry of Trade and Industry. Operating as a global fund, EDBI plays a pivotal role in shaping Singapore's economic landscape by investing in knowledge and innovation-intensive sectors worldwide. Its strategic mandate extends beyond mere financial returns, aiming to attract and grow companies that contribute significantly to Singapore's economic development, foster high-value job creation, and enhance the nation's technological capabilities.
The firm focuses its investments across four key pillars: Healthcare, encompassing biotechnology, medical technology, and digital health; New Technologies, which includes areas like artificial intelligence, robotics, cybersecurity, and advanced manufacturing; Smart & Sustainable Cities, focusing on urban solutions and clean energy; and Emerging Growth, targeting high-potential companies aligned with Singapore's future economic strategies. EDBI typically targets growth-stage companies, often participating in Series B rounds and beyond, though it also considers strategic Series A investments for companies demonstrating strong potential for establishing a significant presence or R&D footprint in Singapore. They seek companies with validated technologies, clear market traction, and a scalable business model.
EDBI's investment cheques typically range from US$3.7 million to US$37 million per company, with the flexibility for larger strategic commitments. This reflects their capacity to support substantial growth and development initiatives. Beyond capital, EDBI actively leverages its extensive network and deep understanding of the Asian market to help portfolio companies expand into Southeast Asia and establish strategic partnerships. Their unique position as a government-backed investor allows them to offer not just funding, but also invaluable support in navigating regulatory landscapes, accessing talent, and fostering an environment conducive to innovation and long-term growth within Singapore.
Investor Profile
EDBI has backed more than 171 startups, with 14 new investments in the last 12 months alone. The firm has led 32 rounds, about 19% of its total and boasts 49 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Series D rounds (top funding stages).
- Majority of deals are located in United States, Singapore, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Software.
- Led 4 rounds in the past year.
- Typical check size: $3.7M – $37M.
Stage Focus
- Series C (24%)
- Series B (18%)
- Series D (16%)
- Series A (13%)
- Series Unknown (13%)
- Series E (5%)
- Seed (3%)
- Series F (2%)
- Private Equity (2%)
- Series G (1%)
Country Focus
- United States (60%)
- Singapore (30%)
- United Kingdom (2%)
- Germany (2%)
- India (2%)
- Switzerland (1%)
- Vietnam (1%)
- Malaysia (1%)
- China (1%)
- Philippines (1%)
Industry Focus
- Biotechnology
- Health Care
- Software
- Medical
- Artificial Intelligence (Ai)
- Information Technology
- Pharmaceutical
- Therapeutics
- Financial Services
- Fintech
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.